MUNICH--GPC, a second-generation genomics-based drug discovery company, has created a US subsidiary, GPC USA, based in Princeton, NJ. John Richard has been named US business development advisor and Gregory Hamm is vice-president of bioinformatics and US site head.
Richard's background includes developing strategic alliances in genomics, drug discovery, and drug delivery. He has been executive vice-
president at Sequus Pharmaceuticals and head of business development at Vivus and at Genome Therapeutics.
Hamm was previously vice-president of bioinformatics at Genome Therapeutics, where he took part in the development and management of several of the company's pharmaceutical alliances, including its first drug-discovery database product. Hamm has been director of the Molecular Biology Computing Laboratory at Rutgers University, principal consultant at Systems & Bioinformatics, and head of computing at the European Molecular Biology Laboratory (EMBL) in Heidelberg. Hamm is also the founder of the EMBL Data Library.